




Searching News Database: progesterone receptor
HSMN NewsFeed - 5 Nov 2018
Biocept Announces New Executive Hires to its Sales and Marketing Organization
Biocept Announces New Executive Hires to its Sales and Marketing Organization
HSMN NewsFeed - 10 Sep 2018
Biocept Names Edwin C. Hendrick as Senior Vice President, Chief Commercial Officer
Biocept Names Edwin C. Hendrick as Senior Vice President, Chief Commercial Officer
HSMN NewsFeed - 10 Oct 2017
Allergan Announces that the FDA Accepts New Drug Application for Ulipristal Acetate for Uterine Fibroids
Allergan Announces that the FDA Accepts New Drug Application for Ulipristal Acetate for Uterine Fibroids
HSMN NewsFeed - 13 Jan 2014
Arno Therapeutics Expands Management Team With Additions of Two Scientific Leaders
Arno Therapeutics Expands Management Team With Additions of Two Scientific Leaders
HSMN NewsFeed - 16 May 2012
Genentech Will Report New Data on Important Progress for People with Advanced Cancers at ASCO 2012
Genentech Will Report New Data on Important Progress for People with Advanced Cancers at ASCO 2012
HSMN NewsFeed - 27 Feb 2012
European Commission Approves Esmya(R) for the Pre-Operative Treatment of Uterine Fibroids (myomas)
European Commission Approves Esmya(R) for the Pre-Operative Treatment of Uterine Fibroids (myomas)
HSMN NewsFeed - 27 May 2008
Node-Negative Early Stage Breast Cancer Patients Benefit from Taxotere(R)-Based Chemotherapy
Node-Negative Early Stage Breast Cancer Patients Benefit from Taxotere(R)-Based Chemotherapy
HSMN NewsFeed - 4 Dec 2007
PregLem SA Announces CHF 36 Million Series B Funding and New Licencing Agreement With HRA Pharma
PregLem SA Announces CHF 36 Million Series B Funding and New Licencing Agreement With HRA Pharma
HSMN NewsFeed - 25 Apr 2007
Celera and LabCorp(R) Announce Licensing Agreement to Commercialize Breast Cancer Testing Assays
Celera and LabCorp(R) Announce Licensing Agreement to Commercialize Breast Cancer Testing Assays
HSMN NewsFeed - 18 Dec 2006
Repros Reports Proellex Achieves Statistically Significant Pain Reduction in Endometriosis Trial
Repros Reports Proellex Achieves Statistically Significant Pain Reduction in Endometriosis Trial
HSMN NewsFeed - 7 Dec 2006
HRA Pharma Commences US Phase III Trial of Second-Generation Emergency Contraceptive
HRA Pharma Commences US Phase III Trial of Second-Generation Emergency Contraceptive
HSMN NewsFeed - 24 Oct 2006
Repros Reports Partial Interim Assessment of Phase 2 Study of Proellex(TM) in Endometriosis
Repros Reports Partial Interim Assessment of Phase 2 Study of Proellex(TM) in Endometriosis
HSMN NewsFeed - 12 Oct 2006
TriPath Imaging Receives FDA 510(k) Clearance for p53 Application for Ventana Image Analysis System
TriPath Imaging Receives FDA 510(k) Clearance for p53 Application for Ventana Image Analysis System
Additional items found! 9

Members Archive contains
9 additional stories matching:
progesterone receptor
(Password required)
progesterone receptor
(Password required)